Showing results (291-300 of 322) with videos related to
Sort By:
Pageof 33
Nature Communications|January 8, 2024
Developmental basis of SHH medulloblastoma heterogeneityMaxwell P Gold, Winnie Ong, Andrew M Masteller, et al.Neuro-Oncology|November 1, 2020
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFRPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.Journal of Neuro-Oncology|November 29, 2018
Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine gliomaMaria Tsoli, Han Shen, Chelsea Mayoh, et al.Journal of Neuro-Oncology|November 18, 2018
International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine gliomaMaria Tsoli, Han Shen, Chelsea Mayoh, et al.Acta Neuropathologica|February 23, 2021
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus studyAnthony P Y Liu, Bryan K Li, Elke Pfaff, et al.Developmental Cell|April 14, 2026
AMBRA1 enhances Sonic Hedgehog signaling during cerebellar development and in medulloblastomaIrene Basili, Francesca Bufalieri, Marilisa Conenna, et al.Nature Medicine|April 24, 2026
Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trialMarie-Anne Debily, Gwenael Le Teuff, Thomas Kergrohen, et al.Neuro-Oncology|May 14, 2024
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma CoalitionPatricia O'Hare, Tabitha Cooney, Peter de Blank, et al.Acta Neuropathologica Communications|November 19, 2024
Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotypeArnault Tauziède-Espariat, Lea L Friker, Gunther Nussbaumer, et al.Cancer Discovery|November 5, 2021
DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial InhibitionElisa Izquierdo, Diana M Carvalho, Alan Mackay, et al.Pageof 33